J. Ohmagari

NFLUENCE OF ETOPOSIDE ON THE LOCAL EFFECT TO RADIATION IN NON-SMALL CELL LUNG CANCER

H. Niibe, Y. Hirokawa, N. Hayabuchi, 1993 .

Type D Dural Carotid—Cavernous Fistula

F. Mihara, A. Mizushima, K. Hasuo, 1996, Acta radiologica.

Comparison of survival rates of patients with nasopharyngeal carcinoma treated with radiotherapy, 5-fluorouracil and vitamin A (“FAR” therapy) vs FAR therapy plus adjunctive cisplatin and peplomycin chemotherapy

Y. Kuratomi, K. Jingu, S. Uehara, 1999, European Archives of Oto-Rhino-Laryngology.

ASSESSMENT OF CHEMO-RADIOTHERAPY FOR CARCINOMA OF THE MAXILLARY SINUS

Y. Kuratomi, K. Masuda, N. Kunitake, 1995 .

Phase Ia study of a hypoxic cell sensitizer doranidazole (PR-350) in combination with conventional radiotherapy

Y. Shibamoto, K. Sasai, M. Sakaguchi, 2001, Anti-cancer drugs.

OPTIMAL DOSE OF FAR-THERAPY FOR LARYNGEAL CANCER

N. Hayabuchi, K. Masuda, M. Miyoshi, 1992 .

BRACHYTHERAPY FOR CARCINOMA OF THE FLOOR OF MOUTH

E. Ariji, K. Masuda, M. Miyoshi, 1994 .